Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma

Clinical trial NCT03989895 · UNKNOWN

Trial details

NCT number: NCT03989895
Sponsor: PrimeVax Immuno-Oncology Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Melanoma

Start date: 2024-04-01
Primary completion: 2024-09-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.